3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
4
Colorectal Neoplasms
4
Head and Neck Neoplasms
2
Diabetes Mellitus
2
Chronic Disease
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sleep Initiation and Maintenance Disorders
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Multiple Myeloma
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lymphoid Interstitial Pneumonia
1
Lymphedema
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Coronary Disease
1
Cardiovascular Diseases
1
Interventions
pembrolizumab
37
Paclitaxel
36
Carboplatin
31
Cyclophosphamide
22
Albumin-Bound Paclitaxel
20
atezolizumab
16
130-nm albumin-bound paclitaxel
16
Taxes
15
Doxorubicin
15
Cisplatin
13
Capecitabine
13
Nivolumab
9
Docetaxel
8
olaparib
7
Gemcitabine
6
Everolimus
6
talazoparib
5
durvalumab
5
Biopsy
5
Bevacizumab
5
veliparib
4
spartalizumab
4
sacituzumab govitecan
4
pegfilgrastim
4
liposomal doxorubicin
4
eribulin
4
Magnetic Resonance Spectroscopy
4
Immunoglobulin G
4
trilaciclib
3
entinostat
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Triple Negative Breast Neoplasms
×
Methods
×
Clear all
No trials found.